Pharma & Healthcare
Global Neurokinin Receptor Antagonists Market Research Report 2024
- Nov 05, 24
- ID: 655386
- Pages: 83
- Figures: 78
- Views: 5
Neurokinin receptor antagonists are a class of medications that inhibit the action of neurokinins by blocking their receptors, primarily neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors. By preventing the binding of neurokinins like substance P and neurokinin B, these antagonists effectively reduce symptoms such as vasomotor symptoms, nausea and vomiting.
The global Neurokinin Receptor Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurokinin Receptor Antagonists include Astellas Pharma, Bayer, Merck, Heron Therapeutics, TerSera Therapeutics, Helsinn Healthcare, Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurokinin Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurokinin Receptor Antagonists.
The Neurokinin Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Neurokinin Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurokinin Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Astellas Pharma
Bayer
Merck
Heron Therapeutics
TerSera Therapeutics
Helsinn Healthcare
Zoetis
Segment by Type
NK-1 Receptor Antagonists
NK-3 Receptor Antagonists
Others
Segment by Application
Vasomotor Symptoms
Nausea and Vomiting
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurokinin Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurokinin Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Neurokinin Receptor Antagonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurokinin Receptor Antagonists include Astellas Pharma, Bayer, Merck, Heron Therapeutics, TerSera Therapeutics, Helsinn Healthcare, Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurokinin Receptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurokinin Receptor Antagonists.
The Neurokinin Receptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Neurokinin Receptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurokinin Receptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Astellas Pharma
Bayer
Merck
Heron Therapeutics
TerSera Therapeutics
Helsinn Healthcare
Zoetis
Segment by Type
NK-1 Receptor Antagonists
NK-3 Receptor Antagonists
Others
Segment by Application
Vasomotor Symptoms
Nausea and Vomiting
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurokinin Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurokinin Receptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Neurokinin Receptor Antagonists Market Overview
1.1 Product Definition
1.2 Neurokinin Receptor Antagonists by Type
1.2.1 Global Neurokinin Receptor Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 NK-1 Receptor Antagonists
1.2.3 NK-3 Receptor Antagonists
1.2.4 Others
1.3 Neurokinin Receptor Antagonists by Application
1.3.1 Global Neurokinin Receptor Antagonists Market Value by Application (2024-2030)
1.3.2 Vasomotor Symptoms
1.3.3 Nausea and Vomiting
1.3.4 Others
1.4 Global Neurokinin Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global Neurokinin Receptor Antagonists Revenue 2019-2030
1.4.2 Global Neurokinin Receptor Antagonists Sales 2019-2030
1.4.3 Global Neurokinin Receptor Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurokinin Receptor Antagonists Market Competition by Manufacturers
2.1 Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurokinin Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurokinin Receptor Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Neurokinin Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurokinin Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurokinin Receptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of Neurokinin Receptor Antagonists, Date of Enter into This Industry
2.8 Global Neurokinin Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global Neurokinin Receptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurokinin Receptor Antagonists Players Market Share by Revenue
2.8.3 Global Neurokinin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurokinin Receptor Antagonists Market Scenario by Region
3.1 Global Neurokinin Receptor Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurokinin Receptor Antagonists Sales by Region: 2019-2030
3.2.1 Global Neurokinin Receptor Antagonists Sales by Region: 2019-2024
3.2.2 Global Neurokinin Receptor Antagonists Sales by Region: 2025-2030
3.3 Global Neurokinin Receptor Antagonists Revenue by Region: 2019-2030
3.3.1 Global Neurokinin Receptor Antagonists Revenue by Region: 2019-2024
3.3.2 Global Neurokinin Receptor Antagonists Revenue by Region: 2025-2030
3.4 North America Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.4.3 North America Neurokinin Receptor Antagonists Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.5.3 Europe Neurokinin Receptor Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurokinin Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific Neurokinin Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurokinin Receptor Antagonists Sales by Region (2019-2030)
3.6.3 Asia Pacific Neurokinin Receptor Antagonists Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.7.3 Latin America Neurokinin Receptor Antagonists Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurokinin Receptor Antagonists Sales by Type (2019-2030)
4.1.1 Global Neurokinin Receptor Antagonists Sales by Type (2019-2024)
4.1.2 Global Neurokinin Receptor Antagonists Sales by Type (2025-2030)
4.1.3 Global Neurokinin Receptor Antagonists Sales Market Share by Type (2019-2030)
4.2 Global Neurokinin Receptor Antagonists Revenue by Type (2019-2030)
4.2.1 Global Neurokinin Receptor Antagonists Revenue by Type (2019-2024)
4.2.2 Global Neurokinin Receptor Antagonists Revenue by Type (2025-2030)
4.2.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global Neurokinin Receptor Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurokinin Receptor Antagonists Sales by Application (2019-2030)
5.1.1 Global Neurokinin Receptor Antagonists Sales by Application (2019-2024)
5.1.2 Global Neurokinin Receptor Antagonists Sales by Application (2025-2030)
5.1.3 Global Neurokinin Receptor Antagonists Sales Market Share by Application (2019-2030)
5.2 Global Neurokinin Receptor Antagonists Revenue by Application (2019-2030)
5.2.1 Global Neurokinin Receptor Antagonists Revenue by Application (2019-2024)
5.2.2 Global Neurokinin Receptor Antagonists Revenue by Application (2025-2030)
5.2.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global Neurokinin Receptor Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Company Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Neurokinin Receptor Antagonists Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Neurokinin Receptor Antagonists Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Neurokinin Receptor Antagonists Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Heron Therapeutics
6.4.1 Heron Therapeutics Company Information
6.4.2 Heron Therapeutics Description and Business Overview
6.4.3 Heron Therapeutics Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Heron Therapeutics Neurokinin Receptor Antagonists Product Portfolio
6.4.5 Heron Therapeutics Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Company Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TerSera Therapeutics Neurokinin Receptor Antagonists Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
6.6 Helsinn Healthcare
6.6.1 Helsinn Healthcare Company Information
6.6.2 Helsinn Healthcare Description and Business Overview
6.6.3 Helsinn Healthcare Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Helsinn Healthcare Neurokinin Receptor Antagonists Product Portfolio
6.6.5 Helsinn Healthcare Recent Developments/Updates
6.7 Zoetis
6.7.1 Zoetis Company Information
6.7.2 Zoetis Description and Business Overview
6.7.3 Zoetis Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Zoetis Neurokinin Receptor Antagonists Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurokinin Receptor Antagonists Industry Chain Analysis
7.2 Neurokinin Receptor Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurokinin Receptor Antagonists Production Mode & Process
7.4 Neurokinin Receptor Antagonists Sales and Marketing
7.4.1 Neurokinin Receptor Antagonists Sales Channels
7.4.2 Neurokinin Receptor Antagonists Distributors
7.5 Neurokinin Receptor Antagonists Customers
8 Neurokinin Receptor Antagonists Market Dynamics
8.1 Neurokinin Receptor Antagonists Industry Trends
8.2 Neurokinin Receptor Antagonists Market Drivers
8.3 Neurokinin Receptor Antagonists Market Challenges
8.4 Neurokinin Receptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Neurokinin Receptor Antagonists by Type
1.2.1 Global Neurokinin Receptor Antagonists Market Value Comparison by Type (2024-2030)
1.2.2 NK-1 Receptor Antagonists
1.2.3 NK-3 Receptor Antagonists
1.2.4 Others
1.3 Neurokinin Receptor Antagonists by Application
1.3.1 Global Neurokinin Receptor Antagonists Market Value by Application (2024-2030)
1.3.2 Vasomotor Symptoms
1.3.3 Nausea and Vomiting
1.3.4 Others
1.4 Global Neurokinin Receptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global Neurokinin Receptor Antagonists Revenue 2019-2030
1.4.2 Global Neurokinin Receptor Antagonists Sales 2019-2030
1.4.3 Global Neurokinin Receptor Antagonists Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurokinin Receptor Antagonists Market Competition by Manufacturers
2.1 Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurokinin Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurokinin Receptor Antagonists Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Neurokinin Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurokinin Receptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurokinin Receptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of Neurokinin Receptor Antagonists, Date of Enter into This Industry
2.8 Global Neurokinin Receptor Antagonists Market Competitive Situation and Trends
2.8.1 Global Neurokinin Receptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurokinin Receptor Antagonists Players Market Share by Revenue
2.8.3 Global Neurokinin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurokinin Receptor Antagonists Market Scenario by Region
3.1 Global Neurokinin Receptor Antagonists Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurokinin Receptor Antagonists Sales by Region: 2019-2030
3.2.1 Global Neurokinin Receptor Antagonists Sales by Region: 2019-2024
3.2.2 Global Neurokinin Receptor Antagonists Sales by Region: 2025-2030
3.3 Global Neurokinin Receptor Antagonists Revenue by Region: 2019-2030
3.3.1 Global Neurokinin Receptor Antagonists Revenue by Region: 2019-2024
3.3.2 Global Neurokinin Receptor Antagonists Revenue by Region: 2025-2030
3.4 North America Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.4.1 North America Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.4.3 North America Neurokinin Receptor Antagonists Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.5.1 Europe Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.5.3 Europe Neurokinin Receptor Antagonists Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurokinin Receptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific Neurokinin Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurokinin Receptor Antagonists Sales by Region (2019-2030)
3.6.3 Asia Pacific Neurokinin Receptor Antagonists Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.7.3 Latin America Neurokinin Receptor Antagonists Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurokinin Receptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurokinin Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurokinin Receptor Antagonists Sales by Type (2019-2030)
4.1.1 Global Neurokinin Receptor Antagonists Sales by Type (2019-2024)
4.1.2 Global Neurokinin Receptor Antagonists Sales by Type (2025-2030)
4.1.3 Global Neurokinin Receptor Antagonists Sales Market Share by Type (2019-2030)
4.2 Global Neurokinin Receptor Antagonists Revenue by Type (2019-2030)
4.2.1 Global Neurokinin Receptor Antagonists Revenue by Type (2019-2024)
4.2.2 Global Neurokinin Receptor Antagonists Revenue by Type (2025-2030)
4.2.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2019-2030)
4.3 Global Neurokinin Receptor Antagonists Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurokinin Receptor Antagonists Sales by Application (2019-2030)
5.1.1 Global Neurokinin Receptor Antagonists Sales by Application (2019-2024)
5.1.2 Global Neurokinin Receptor Antagonists Sales by Application (2025-2030)
5.1.3 Global Neurokinin Receptor Antagonists Sales Market Share by Application (2019-2030)
5.2 Global Neurokinin Receptor Antagonists Revenue by Application (2019-2030)
5.2.1 Global Neurokinin Receptor Antagonists Revenue by Application (2019-2024)
5.2.2 Global Neurokinin Receptor Antagonists Revenue by Application (2025-2030)
5.2.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2019-2030)
5.3 Global Neurokinin Receptor Antagonists Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Company Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Neurokinin Receptor Antagonists Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Neurokinin Receptor Antagonists Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Neurokinin Receptor Antagonists Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Heron Therapeutics
6.4.1 Heron Therapeutics Company Information
6.4.2 Heron Therapeutics Description and Business Overview
6.4.3 Heron Therapeutics Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Heron Therapeutics Neurokinin Receptor Antagonists Product Portfolio
6.4.5 Heron Therapeutics Recent Developments/Updates
6.5 TerSera Therapeutics
6.5.1 TerSera Therapeutics Company Information
6.5.2 TerSera Therapeutics Description and Business Overview
6.5.3 TerSera Therapeutics Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TerSera Therapeutics Neurokinin Receptor Antagonists Product Portfolio
6.5.5 TerSera Therapeutics Recent Developments/Updates
6.6 Helsinn Healthcare
6.6.1 Helsinn Healthcare Company Information
6.6.2 Helsinn Healthcare Description and Business Overview
6.6.3 Helsinn Healthcare Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Helsinn Healthcare Neurokinin Receptor Antagonists Product Portfolio
6.6.5 Helsinn Healthcare Recent Developments/Updates
6.7 Zoetis
6.7.1 Zoetis Company Information
6.7.2 Zoetis Description and Business Overview
6.7.3 Zoetis Neurokinin Receptor Antagonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Zoetis Neurokinin Receptor Antagonists Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurokinin Receptor Antagonists Industry Chain Analysis
7.2 Neurokinin Receptor Antagonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurokinin Receptor Antagonists Production Mode & Process
7.4 Neurokinin Receptor Antagonists Sales and Marketing
7.4.1 Neurokinin Receptor Antagonists Sales Channels
7.4.2 Neurokinin Receptor Antagonists Distributors
7.5 Neurokinin Receptor Antagonists Customers
8 Neurokinin Receptor Antagonists Market Dynamics
8.1 Neurokinin Receptor Antagonists Industry Trends
8.2 Neurokinin Receptor Antagonists Market Drivers
8.3 Neurokinin Receptor Antagonists Market Challenges
8.4 Neurokinin Receptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Neurokinin Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Neurokinin Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Neurokinin Receptor Antagonists Market Competitive Situation by Manufacturers in 2023
Table 4. Global Neurokinin Receptor Antagonists Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Neurokinin Receptor Antagonists Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Neurokinin Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Neurokinin Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neurokinin Receptor Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurokinin Receptor Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of Neurokinin Receptor Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurokinin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurokinin Receptor Antagonists as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurokinin Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Neurokinin Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 18. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2019-2024)
Table 19. Global Neurokinin Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 20. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2025-2030)
Table 21. Global Neurokinin Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2019-2024)
Table 23. Global Neurokinin Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2025-2030)
Table 25. North America Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 27. North America Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 28. North America Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Neurokinin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 32. Europe Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 33. Europe Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Neurokinin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Neurokinin Receptor Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Neurokinin Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Neurokinin Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Neurokinin Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Neurokinin Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Neurokinin Receptor Antagonists Sales (K Units) by Type (2019-2024)
Table 51. Global Neurokinin Receptor Antagonists Sales (K Units) by Type (2025-2030)
Table 52. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2019-2024)
Table 53. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2025-2030)
Table 54. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 57. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 58. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Type (2019-2024)
Table 59. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Type (2025-2030)
Table 60. Global Neurokinin Receptor Antagonists Sales (K Units) by Application (2019-2024)
Table 61. Global Neurokinin Receptor Antagonists Sales (K Units) by Application (2025-2030)
Table 62. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2019-2024)
Table 63. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2025-2030)
Table 64. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2019-2024)
Table 67. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2025-2030)
Table 68. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Application (2019-2024)
Table 69. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Application (2025-2030)
Table 70. Astellas Pharma Company Information
Table 71. Astellas Pharma Description and Business Overview
Table 72. Astellas Pharma Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Astellas Pharma Neurokinin Receptor Antagonists Product
Table 74. Astellas Pharma Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Neurokinin Receptor Antagonists Product
Table 79. Bayer Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Neurokinin Receptor Antagonists Product
Table 84. Merck Recent Developments/Updates
Table 85. Heron Therapeutics Company Information
Table 86. Heron Therapeutics Description and Business Overview
Table 87. Heron Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Heron Therapeutics Neurokinin Receptor Antagonists Product
Table 89. Heron Therapeutics Recent Developments/Updates
Table 90. TerSera Therapeutics Company Information
Table 91. TerSera Therapeutics Description and Business Overview
Table 92. TerSera Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. TerSera Therapeutics Neurokinin Receptor Antagonists Product
Table 94. TerSera Therapeutics Recent Developments/Updates
Table 95. Helsinn Healthcare Company Information
Table 96. Helsinn Healthcare Description and Business Overview
Table 97. Helsinn Healthcare Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Helsinn Healthcare Neurokinin Receptor Antagonists Product
Table 99. Helsinn Healthcare Recent Developments/Updates
Table 100. Zoetis Company Information
Table 101. Zoetis Description and Business Overview
Table 102. Zoetis Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Zoetis Neurokinin Receptor Antagonists Product
Table 104. Zoetis Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Neurokinin Receptor Antagonists Distributors List
Table 108. Neurokinin Receptor Antagonists Customers List
Table 109. Neurokinin Receptor Antagonists Market Trends
Table 110. Neurokinin Receptor Antagonists Market Drivers
Table 111. Neurokinin Receptor Antagonists Market Challenges
Table 112. Neurokinin Receptor Antagonists Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurokinin Receptor Antagonists
Figure 2. Global Neurokinin Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Neurokinin Receptor Antagonists Market Share by Type: 2023 & 2030
Figure 4. NK-1 Receptor Antagonists Product Picture
Figure 5. NK-3 Receptor Antagonists Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neurokinin Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Neurokinin Receptor Antagonists Market Share by Application: 2023 & 2030
Figure 9. Vasomotor Symptoms
Figure 10. Nausea and Vomiting
Figure 11. Others
Figure 12. Global Neurokinin Receptor Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Neurokinin Receptor Antagonists Market Size (2019-2030) & (US$ Million)
Figure 14. Global Neurokinin Receptor Antagonists Sales (2019-2030) & (K Units)
Figure 15. Global Neurokinin Receptor Antagonists Average Price (US$/Unit) & (2019-2030)
Figure 16. Neurokinin Receptor Antagonists Report Years Considered
Figure 17. Neurokinin Receptor Antagonists Sales Share by Manufacturers in 2023
Figure 18. Global Neurokinin Receptor Antagonists Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Neurokinin Receptor Antagonists Players: Market Share by Revenue in Neurokinin Receptor Antagonists in 2023
Figure 20. Neurokinin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Neurokinin Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 23. North America Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 24. United States Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 27. Europe Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 28. Germany Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Neurokinin Receptor Antagonists Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Neurokinin Receptor Antagonists Revenue Market Share by Region (2019-2030)
Figure 35. China Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 43. Mexico Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Neurokinin Receptor Antagonists by Type (2019-2030)
Figure 53. Global Revenue Market Share of Neurokinin Receptor Antagonists by Type (2019-2030)
Figure 54. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Neurokinin Receptor Antagonists by Application (2019-2030)
Figure 56. Global Revenue Market Share of Neurokinin Receptor Antagonists by Application (2019-2030)
Figure 57. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Application (2019-2030)
Figure 58. Neurokinin Receptor Antagonists Value Chain
Figure 59. Neurokinin Receptor Antagonists Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Neurokinin Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Neurokinin Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Neurokinin Receptor Antagonists Market Competitive Situation by Manufacturers in 2023
Table 4. Global Neurokinin Receptor Antagonists Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Neurokinin Receptor Antagonists Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Neurokinin Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Neurokinin Receptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neurokinin Receptor Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurokinin Receptor Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of Neurokinin Receptor Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurokinin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurokinin Receptor Antagonists as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurokinin Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Neurokinin Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 18. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2019-2024)
Table 19. Global Neurokinin Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 20. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2025-2030)
Table 21. Global Neurokinin Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2019-2024)
Table 23. Global Neurokinin Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2025-2030)
Table 25. North America Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 27. North America Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 28. North America Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Neurokinin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 32. Europe Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 33. Europe Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Neurokinin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Neurokinin Receptor Antagonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Neurokinin Receptor Antagonists Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Neurokinin Receptor Antagonists Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Neurokinin Receptor Antagonists Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Neurokinin Receptor Antagonists Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Neurokinin Receptor Antagonists Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Neurokinin Receptor Antagonists Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Neurokinin Receptor Antagonists Sales (K Units) by Type (2019-2024)
Table 51. Global Neurokinin Receptor Antagonists Sales (K Units) by Type (2025-2030)
Table 52. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2019-2024)
Table 53. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2025-2030)
Table 54. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 57. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 58. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Type (2019-2024)
Table 59. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Type (2025-2030)
Table 60. Global Neurokinin Receptor Antagonists Sales (K Units) by Application (2019-2024)
Table 61. Global Neurokinin Receptor Antagonists Sales (K Units) by Application (2025-2030)
Table 62. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2019-2024)
Table 63. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2025-2030)
Table 64. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Neurokinin Receptor Antagonists Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2019-2024)
Table 67. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2025-2030)
Table 68. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Application (2019-2024)
Table 69. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Application (2025-2030)
Table 70. Astellas Pharma Company Information
Table 71. Astellas Pharma Description and Business Overview
Table 72. Astellas Pharma Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Astellas Pharma Neurokinin Receptor Antagonists Product
Table 74. Astellas Pharma Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Neurokinin Receptor Antagonists Product
Table 79. Bayer Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Neurokinin Receptor Antagonists Product
Table 84. Merck Recent Developments/Updates
Table 85. Heron Therapeutics Company Information
Table 86. Heron Therapeutics Description and Business Overview
Table 87. Heron Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Heron Therapeutics Neurokinin Receptor Antagonists Product
Table 89. Heron Therapeutics Recent Developments/Updates
Table 90. TerSera Therapeutics Company Information
Table 91. TerSera Therapeutics Description and Business Overview
Table 92. TerSera Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. TerSera Therapeutics Neurokinin Receptor Antagonists Product
Table 94. TerSera Therapeutics Recent Developments/Updates
Table 95. Helsinn Healthcare Company Information
Table 96. Helsinn Healthcare Description and Business Overview
Table 97. Helsinn Healthcare Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Helsinn Healthcare Neurokinin Receptor Antagonists Product
Table 99. Helsinn Healthcare Recent Developments/Updates
Table 100. Zoetis Company Information
Table 101. Zoetis Description and Business Overview
Table 102. Zoetis Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Zoetis Neurokinin Receptor Antagonists Product
Table 104. Zoetis Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Neurokinin Receptor Antagonists Distributors List
Table 108. Neurokinin Receptor Antagonists Customers List
Table 109. Neurokinin Receptor Antagonists Market Trends
Table 110. Neurokinin Receptor Antagonists Market Drivers
Table 111. Neurokinin Receptor Antagonists Market Challenges
Table 112. Neurokinin Receptor Antagonists Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurokinin Receptor Antagonists
Figure 2. Global Neurokinin Receptor Antagonists Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Neurokinin Receptor Antagonists Market Share by Type: 2023 & 2030
Figure 4. NK-1 Receptor Antagonists Product Picture
Figure 5. NK-3 Receptor Antagonists Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neurokinin Receptor Antagonists Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Neurokinin Receptor Antagonists Market Share by Application: 2023 & 2030
Figure 9. Vasomotor Symptoms
Figure 10. Nausea and Vomiting
Figure 11. Others
Figure 12. Global Neurokinin Receptor Antagonists Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Neurokinin Receptor Antagonists Market Size (2019-2030) & (US$ Million)
Figure 14. Global Neurokinin Receptor Antagonists Sales (2019-2030) & (K Units)
Figure 15. Global Neurokinin Receptor Antagonists Average Price (US$/Unit) & (2019-2030)
Figure 16. Neurokinin Receptor Antagonists Report Years Considered
Figure 17. Neurokinin Receptor Antagonists Sales Share by Manufacturers in 2023
Figure 18. Global Neurokinin Receptor Antagonists Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Neurokinin Receptor Antagonists Players: Market Share by Revenue in Neurokinin Receptor Antagonists in 2023
Figure 20. Neurokinin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Neurokinin Receptor Antagonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 23. North America Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 24. United States Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 27. Europe Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 28. Germany Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Neurokinin Receptor Antagonists Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Neurokinin Receptor Antagonists Revenue Market Share by Region (2019-2030)
Figure 35. China Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 43. Mexico Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Neurokinin Receptor Antagonists Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Neurokinin Receptor Antagonists Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Neurokinin Receptor Antagonists Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Neurokinin Receptor Antagonists by Type (2019-2030)
Figure 53. Global Revenue Market Share of Neurokinin Receptor Antagonists by Type (2019-2030)
Figure 54. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Neurokinin Receptor Antagonists by Application (2019-2030)
Figure 56. Global Revenue Market Share of Neurokinin Receptor Antagonists by Application (2019-2030)
Figure 57. Global Neurokinin Receptor Antagonists Price (US$/Unit) by Application (2019-2030)
Figure 58. Neurokinin Receptor Antagonists Value Chain
Figure 59. Neurokinin Receptor Antagonists Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232